BDD Chairman to joint chair SMI - Controlled Release Delivery conference

Our Chairman Howard Stevens is joint chair for the SMI - Controlled Release Delivery conference in London Mar 21st - 22nd. Showing our latest advances in controlled release technology.

KEYNOTE ADDRESS 1.30 Multi phasic oral drug delivery - in-vivo opportunities and challenges • What mechanisms define complex oral drug delivery profiles? • The release of drug from complex oral drug delivery systems should be entirely independent of patient factors such as pH and GI motility. • Case study: OralogiKTM - an erosion based technology Howard Stevens, Emeritus Professor, University of Strathclyde https://www.smi-online.co.uk/pharmaceuticals/uk/controlled-release https://www.smi-online.co.uk/_media/docs/event_5289.pdf

Featured Posts
Recent Posts
Archive
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square

          BDD Ltd

 

CLINICAL SITE:   BDD Pharma Ltd

Glasgow Royal Infirmary

84 Castle St

Glasgow

G4 0SF, UK

FORMULATION SITE:  BDD Pharma Ltd

Bio-City Scotland

Bo'ness Road

Chapelhall, Newhouse

ML1 5UH, UK

Contact Us

Clinical Site. +44 (0)141 552 8791

Formulation site. +44 (0)141 552 7752

email. enquiries@bddpharma.com

 

Social Media

  • LinkedIn - White Circle
  • Twitter - White Circle
  • YouTube - White Circle
  • Facebook - White Circle

Registered in Scotland No. 212868        Privacy Policy     Acceptable Use     Terms of Use   

@2020 BDD Ltd